Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SBC vs FORR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 8–2 Matrix Metrics)

SBC Overall Winner 6-Pillar Tally: SBC 4 – 1 FORR (1 Tie) Matrix Metrics: SBC 8 – 2 FORR

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Forrester Research Inc (FORR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin), whereas FORR carries 57.2/100 (HOLD) at $8.64 (9.6x Forward P/E, 0.3% operating margin).

  • Composite vs. Pillar Nuance: While FORR currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 0.3% operating margin) and revenue trajectory (+35.1% vs. -8.7% YoY).
  • Technical & Structure Timing Caution: SBC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.2); meanwhile FORR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SBC vs FORR
SBC NASDAQ Head-to-Head Winner
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap $574.4M
TTM Revenue $190M
Forward P/E 9.0x
Beta / 30D Vol 0.96β · 159% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 41.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.2 · SMA20: $5.54 · SMA50: $5.28
FORR NASDAQ
Forrester Research Inc
Services-Engineering, Accounting, Research, Management
$8.64
-1.37% 1D
Market Cap $159.0M
TTM Revenue $373M
Forward P/E 9.6x
Beta / 30D Vol 0.57β · 54% Vol
Unified Composite Score
57.2 / 100 HOLD
Tech 66.0 Fund 61.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28
RSI-14: 28.4 · SMA20: $9.74 · SMA50: $10.88

6-Pillar Scorecard Institutional Category Breakdown (SBC 4 – 1 FORR)

Columns: Metric · SBC · FORR
1. Valuation Multiples SBC
Forward P/E 9.0x 9.6x
Trailing P/E 11.0x 14.1x
PEG Ratio 2.40x 1.01x
EV / Revenue 3.0x 0.4x
2. Growth & Scale SBC
Revenue Growth (YoY) +35.1% -8.7%
Earnings Growth (YoY) +22.4% +290.0%
TTM Revenue (USD) $190M $373M
Market Cap $574.4M $159.0M
3. Profitability & Quality SBC
Gross Margin 72.2% 56.9%
Operating Margin 39.9% 0.3%
Net Profit Margin 27.3% -12.0%
Return on Equity (ROE) 19.3% -33.6%
4. Balance Sheet & Cash Flow SBC
Cash Generation (TTM) $80M EBITDA $12M EBITDA
Cash Flow Margin 41.8% EBITDA Mgn 3.2% EBITDA Mgn
Net Cash / Leverage $2.79 Book/Sh · 19.3% ROE $5.90 Book/Sh · -33.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 133.6% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat FORR
OpEx & R&D Intensity 32.3% of Rev ($61M) 56.6% of Rev ($211M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SBC (8) vs FORR (2)
Institutional Metric SBC FORR Criterion Row Edge
Market Capitalization
Scale
$574.4M $159.0M Larger Scale SBC
Trailing P/E Ratio
Valuation
11.0x 14.1x Lower Multiple SBC
Forward P/E Ratio
Valuation
9.0x 9.6x Lower Multiple SBC
Revenue Growth (YoY)
Growth
+35.1% -8.7% Higher Growth SBC
Operating Margin (TTM)
Profitability
39.9% 0.3% Higher Margin SBC
Net Profit Margin
Profitability
27.3% -12.0% Higher Margin SBC
Return on Equity (ROE)
Capital Efficiency
19.3% -33.6% Higher ROE SBC
52-Week Range Position
Momentum
52% ($3–$7) 48% ($5–$13) Stronger Trend SBC
Beta / 30D Volatility
Risk Regime
0.96β · 159% Vol 0.57β · 54% Vol Lower Realized Risk FORR
Unified Institutional Score
Composite Signal
47.2 / 100 (HOLD) 57.2 / 100 (HOLD) Higher Composite FORR
Trailing 12M Revenue (USD)
Operating Scale
$190M $373M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.2% 56.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.40x PEG · 3.0x EV/Rev 1.01x PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$80M EBITDA ($2.79 Book/Sh · 19.3% ROE) $12M EBITDA ($5.90 Book/Sh · -33.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBC +21.41 pp
SBC: -9.14% · FORR: -30.55%
3M Horizon SBC +52.46 pp
SBC: +24.58% · FORR: -27.88%
6M Horizon SBC +40.59 pp
SBC: +68.4% · FORR: +27.81%
1Y Horizon SBC +38.57 pp
SBC: +63.61% · FORR: +25.04%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBC vs FORR. Trailing 12-month operating profitability (SBC 39.9% vs FORR 0.3%) and valuation multiples (SBC 9.0x vs FORR 9.6x Forward P/E) are benchmarked directly in Pillar 4 below.

SBC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$190M
Gross Margin72.2%
Op. Margin39.9%
ROE / Fwd P/E19.3% · 9.0x
FORR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$373M
Gross Margin56.9%
Op. Margin0.3%
ROE / Fwd P/E-33.6% · 9.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SBC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FORR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 133.6%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FORR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SBC Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $574.4M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment 32.3% of Rev ($61M)
90D Engineering Disclosures 0 Published
FORR Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $159.0M market capitalization and 0.3% operating margin.
OpEx & R&D Reinvestment 56.6% of Rev ($211M)
90D Engineering Disclosures 0 Published

Investor FAQ SBC vs FORR Key Questions & Quantitative Answers

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Forrester Research Inc (FORR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin), whereas FORR carries 57.2/100 (HOLD) at $8.64 (9.6x Forward P/E, 0.3% operating margin). Composite vs. Pillar Nuance: While FORR currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 0.3% operating margin) and revenue trajectory (+35.1% vs. -8.7% YoY). Technical & Structure Timing Caution: SBC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.2); meanwhile FORR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBC leads the Growth & Scale pillar: SBC posts +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin), compared with FORR at -8.7% YoY revenue growth and +290.0% YoY earnings growth on $373M TTM revenue (56.9% gross margin, 0.3% operating margin). On trailing 12-month operating scale, SBC generates $190M in USD-normalized revenue versus $373M for FORR. In operating R&D and SG&A reinvestment, SBC deploys 32.3% of Rev ($61M) (0 90-day corporate R&D disclosures) versus 56.6% of Rev ($211M) (0 disclosures) for FORR.

SBC screens cheaper on headline valuation multiples. SBC trades at 9.0x Forward P/E, 11.0x Trailing P/E, 2.40x PEG, and 3.0x EV/Revenue (41.8% EBITDA margin), whereas FORR trades at 9.6x Forward P/E, 14.1x Trailing P/E, 1.01x PEG, and 0.4x EV/Revenue (3.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBC (19.3% ROE) versus FORR (-33.6% ROE) capital efficiency.

In options market volatility and institutional positioning, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 159% Vol realized risk). By comparison, FORR carries 133.6% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 54% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.